Antibodies Products & Reviews

The JAX Therapeutic Antibody Evaluation Services rely on a unique humanized mouse collection. Using its humanized FcRn models to deliver accurate data and get therapeutic candidates into the clinic—and ultimately in the hands of physicians and patients—faster.

Recombinant monoclonal antibody to ENG. It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Adult Solid Tumor, Advanced Soft Tissue Sarcoma, Metastatic Breast Cancer, Solid Tumors, Lung Cancer...

This product is a recombinant Human antibody that recognizes CRCP. The antibody was purified by affinity chromatography.

This product is a Human antibody that recognizes Human HLA-A*11:01.

This product is a Mouse antibody that recognizes Human Fc P329G LALA.

Recombinant monoclonal antibody to 4-1BB. This anti-4-1BB antibody is a fully human IgG4 monoclonal antibody targeting the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.

This product is a human IgG1, κ antibody that can recognize human NECTIN4.

Recombinant human monoclonal antibody expressed in CHO binds to the human interferon α/β receptor. It is a monoclonal antibody designed for the treatment of systemic lupus erythematosus.

This recombinant monoclonal antibody is a humanized monoclonal antibody that specifically recognizes human IL-23A and has potent affinity against IL-23A. It can also be potentially used in the research of Crohn's disease, psoriasis, psoriatic arthritis, and asthma.

Recombinant Human Antibody (M22) is capable of binding to TSHR, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-TSHR mAb and the CH1-3 region of human IgG and a light chain (LC) encoding VL from anti-TSHR mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.

Recombinant Human Antibody (FI6V3) is capable of binding to IAV HA, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-IAV HA mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-IAV HA mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.

Recombinant Human Antibody (K1-70) is capable of binding to the TSH receptor (TSHR), expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-TSH receptor (TSHR) mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-TSH receptor (TSHR) proteins mAb and CL of human kappa light chain.

This product is a recombinant Human antibody that recognizes PDCD1. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

Recombinant Human Antibody (D25) is capable of binding to RSV, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-RSV mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-RSV mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.

The antibody specifically targets the CD3 epsilon chain present on T lymphocytes. It binds to the CD3 molecule on the surface of T cells. By engaging with CD3, the mAb alters the immune response, offering potential in decelerating the progression of type 1 diabetes.

This product is a human monoclonal IgG1 kappan antibody targeting the Gnl domain of glycoprotein N (Gn) of severe fever with thrombocytopenia syndrome virus (SFTSV). This antibody shows the ability to neutralize SFTSV broadly, using the antibody neutralization of the SFTSV, which makes the antibody a specific drug and so clinically useful in preventing SFTSV through the treatment studies of diseases caused by infection.

Recombinant monoclonal antibody to Human VEGF is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels. It is licensed to treat various cancers, including colorectal, lung, breast (outside the USA), glioblastoma (USA only), kidney, and ovarian. Bevacizumab is a humanized monoclonal antibody that inhibits angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).

Recombinant monoclonal antibody to IL5RA. It is a monoclonal antibody for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).

Recombinant Mouse Antibody (M75) is capable of binding to CA9. The adhesion site of CA IX appears to overlap with the PGEEDLP epitope of the monoclonal antibody M75, since the antibody blocks attachment of cells to immobilized CA IX protein.

Recombinant monoclonal antibody to CD274. This antibody is a human IgG1 monoclonal antibody that targets and binds to PD-L1, a protein that is often overexpressed on the surface of cancer cells and immune cells in the tumor microenvironment.

Recombinant monoclonal antibody to Human IL5. It is a humanized monoclonal antibody that recognizes interleukin-5 (IL-5) and is used to treat certain kinds of asthma and white blood cell diseases. Recent studies have concluded that mepolizumab may improve exacerbations in patients with severe eosinophilic asthma, an adult-onset asthma that represents less than 5% of all asthma.

Recombinant monoclonal antibody to Human EGFR. Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1, and HER1 in humans).

This product is a recombinant Human antibody that recognizes MS4A1/CD20. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

This product is a recombinant Mouse antibody that recognizes DOTA. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

Recombinant Rabbit Antibody is capable of binding to Hypusine, expressed in Chinese Hamster Ovary cells (CHO).